z-logo
Premium
The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS‐TFCP2 fusion transcript
Author(s) -
Brunac AnneCécile,
Laprie Anne,
Castex MariePierre,
Laurent Camille,
Le Loarer François,
Karanian Marie,
Le Guellec Sophie,
Guillemot Delphine,
Pierron Gaelle,
GomezBrouchet Anne
Publication year - 2020
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28185
Subject(s) - medicine , rhabdomyosarcoma , fusion transcript , fusion gene , cancer research , radiation therapy , computational biology , bioinformatics , sarcoma , pathology , gene , genetics , biology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom